Physician profile
Prakash Krishnan
NPI 1972547974
$387,073.08
in general payments reported to CMS, 2019-2025
37 companies · $132K in 2025
The $132K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $63K · 2021: $11K · 2022: $27K · 2023: $32K · 2024: $74K · 2025: $132K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $76K · Travel and Lodging: $66K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Food and Beverage: $34K · Acquisitions: $16K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $76,129.38 |
| Travel and Lodging | $66,263.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,308.75 |
| Food and Beverage | $33,779.17 |
| Acquisitions | $15,531.82 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $176,716.98 | 2019-2025 | Supera, Perclose Proglide, Esprit |
| Medtronic, INC. | $82,942.86 | 2021-2025 | Hawkone, Symplicity G3, In.Pact Admiral |
| W. L. Gore & Associates, INC. | $38,860.20 | 2020-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Medtronic Vascular, INC. | $19,992.71 | 2019-2020 | |
| Boston Scientific Corporation | $15,567.93 | 2019-2025 | General - Therapies |
| Philips North America LLC | $15,387.33 | 2019-2025 | IV Other, Peripheral Vascular Undivided, Stellarex |
| Asahi Intecc Co., Ltd. | $14,913.38 | 2024-2025 | Crosslead, Peripheral Vascular |
| Shockwave Medical, INC | $5,416.08 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $4,194.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Incorporated | $2,760.00 | 2019-2025 | |
| Terumo Medical Corporation | $2,110.35 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $2,074.78 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Venclose Maven Catheter |
| Endologix LLC | $2,045.67 | 2023-2024 | Torus Stent Graft System, Endocross Device |
| Asahi Intecc USA, INC. | $869.12 | 2024 | Peripheral Vascular |
| Cook Medical LLC | $678.37 | 2019-2025 | Zilver Ptx |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $335.83 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Cardiovascular Systems INC. | $300.12 | 2019-2022 | |
| Cordis US Corp. | $239.50 | 2024-2025 | Mynx Control Venous, Selution Slrpta, Mynx Venous Vcd |
| Becton, Dickinson and Company | $232.20 | 2024 | Venovo |
| Contego Medical, INC | $210.46 | 2023 | |
| Recor Medical INC | $195.76 | 2024 | Paradise Renal Denervation System |
| Cagent Vascular INC | $152.69 | 2022-2025 | Serrantor |
| Amgen INC. | $139.80 | 2019-2025 | Repatha |
| Stryker Corporation | $133.06 | 2025 | Limflow System, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $119.17 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.96 | 2019-2022 | |
| Surmodics, INC. | $80.72 | 2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Penumbra, INC. | $78.41 | 2019-2020 | |
| Advanced Oxygen Therapy INC. | $67.87 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $36.52 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $26.62 | 2024 | Xarelto |
| Cardiva Medical, INC. | $23.15 | 2020 | |
| Chiesi USA, INC. | $22.52 | 2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $20.15 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $16.24 | 2021 | |
| Intact Vascular, INC. | $8.76 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$29,859.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prakash Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.